Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Personality Inventory | 2 | 2008 | 134 | 0.280 |
Why?
|
| Bioterrorism | 1 | 2007 | 31 | 0.250 |
Why?
|
| Disaster Planning | 1 | 2007 | 110 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2008 | 902 | 0.220 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 420 | 0.190 |
Why?
|
| Mental Health Services | 1 | 2007 | 478 | 0.170 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 2416 | 0.100 |
Why?
|
| N-Methylaspartate | 2 | 2005 | 43 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 173 | 0.060 |
Why?
|
| Europe | 1 | 2008 | 426 | 0.060 |
Why?
|
| Somatoform Disorders | 1 | 2007 | 34 | 0.060 |
Why?
|
| Absenteeism | 1 | 2007 | 52 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2008 | 537 | 0.060 |
Why?
|
| Myocardial Infarction | 3 | 1998 | 1213 | 0.060 |
Why?
|
| Health Services | 1 | 2007 | 113 | 0.060 |
Why?
|
| Receptor, trkB | 1 | 2005 | 39 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 174 | 0.050 |
Why?
|
| Psychometrics | 1 | 2008 | 739 | 0.050 |
Why?
|
| Neurons | 2 | 2005 | 1672 | 0.050 |
Why?
|
| Prevalence | 2 | 2008 | 2889 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2005 | 149 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2017 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2005 | 256 | 0.050 |
Why?
|
| Dizocilpine Maleate | 1 | 2001 | 24 | 0.040 |
Why?
|
| Familial Mediterranean Fever | 1 | 2001 | 7 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 75 | 0.040 |
Why?
|
| Amyloidosis | 1 | 2001 | 45 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2001 | 155 | 0.040 |
Why?
|
| Exons | 1 | 2001 | 365 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 3448 | 0.040 |
Why?
|
| United States | 2 | 2008 | 16313 | 0.040 |
Why?
|
| Mass Screening | 1 | 2008 | 1375 | 0.040 |
Why?
|
| Cerebellum | 1 | 2001 | 227 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 233 | 0.040 |
Why?
|
| Myocardial Ischemia | 2 | 1998 | 287 | 0.040 |
Why?
|
| Military Personnel | 1 | 2007 | 749 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 28 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2001 | 676 | 0.030 |
Why?
|
| Myocardium | 2 | 1998 | 947 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2001 | 600 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1998 | 892 | 0.020 |
Why?
|
| Kidney | 1 | 2001 | 1511 | 0.020 |
Why?
|
| Apoptosis | 1 | 1997 | 2454 | 0.020 |
Why?
|
| Male | 6 | 2008 | 73950 | 0.020 |
Why?
|
| Humans | 5 | 2008 | 147293 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 2542 | 0.020 |
Why?
|
| Iraq | 1 | 2007 | 67 | 0.020 |
Why?
|
| Combat Disorders | 1 | 2007 | 42 | 0.020 |
Why?
|
| Rabbits | 2 | 1997 | 654 | 0.010 |
Why?
|
| Warfare | 1 | 2007 | 100 | 0.010 |
Why?
|
| Coronary Vessels | 2 | 1998 | 246 | 0.010 |
Why?
|
| Life Change Events | 1 | 2007 | 149 | 0.010 |
Why?
|
| Female | 4 | 2008 | 80076 | 0.010 |
Why?
|
| Indole Alkaloids | 1 | 2005 | 7 | 0.010 |
Why?
|
| Butadienes | 1 | 2005 | 33 | 0.010 |
Why?
|
| Chromones | 1 | 2005 | 43 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2005 | 45 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 53 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2001 | 1721 | 0.010 |
Why?
|
| Carbazoles | 1 | 2005 | 53 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 108 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 126 | 0.010 |
Why?
|
| Rats | 2 | 2005 | 5613 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 130 | 0.010 |
Why?
|
| Nitriles | 1 | 2005 | 211 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 241 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 762 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 1186 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 1672 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2001 | 50 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 822 | 0.010 |
Why?
|
| Health Status | 1 | 2007 | 839 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 60 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2001 | 141 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 255 | 0.010 |
Why?
|
| Abdomen | 1 | 2001 | 142 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1481 | 0.010 |
Why?
|
| Macrophages | 2 | 1998 | 1529 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2007 | 951 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 800 | 0.010 |
Why?
|
| Nitrate Reductases | 1 | 1998 | 1 | 0.010 |
Why?
|
| Nitrate Reductase | 1 | 1998 | 1 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 1998 | 52 | 0.010 |
Why?
|
| Nitrites | 1 | 1998 | 88 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1998 | 75 | 0.010 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 1997 | 4 | 0.010 |
Why?
|
| Veins | 1 | 1998 | 69 | 0.010 |
Why?
|
| Diastole | 1 | 1998 | 147 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 977 | 0.010 |
Why?
|
| Animals | 4 | 2005 | 38410 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 589 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1997 | 31 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 1319 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 1569 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 43 | 0.010 |
Why?
|
| Nitrates | 1 | 1998 | 97 | 0.010 |
Why?
|
| Biotin | 1 | 1997 | 32 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 2175 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 234 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1997 | 154 | 0.010 |
Why?
|
| Calmodulin | 1 | 1997 | 70 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1997 | 96 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1997 | 153 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 1997 | 94 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2812 | 0.010 |
Why?
|
| Arteries | 1 | 1998 | 262 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1997 | 190 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1998 | 329 | 0.010 |
Why?
|
| Perfusion | 1 | 1997 | 252 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1997 | 212 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 342 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1998 | 546 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 1077 | 0.010 |
Why?
|
| Cell Survival | 1 | 1997 | 1111 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1488 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 6164 | 0.010 |
Why?
|
| Heart Rate | 1 | 1997 | 860 | 0.010 |
Why?
|
| Calcium | 1 | 1997 | 1197 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 5272 | 0.010 |
Why?
|
| DNA | 1 | 1997 | 1444 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 2791 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 5476 | 0.000 |
Why?
|
| Middle Aged | 2 | 2001 | 36821 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 8430 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2001 | 17560 | 0.000 |
Why?
|
| Aged | 1 | 1998 | 26514 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 41405 | 0.000 |
Why?
|